Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs

Slides:



Advertisements
Similar presentations
TUBERCULOSIS This is the prompt slide for the TB Therapy section.
Advertisements

TUBERCULOSIS Pulmonary TB.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs.
Antifungal Drugs: Actions and Uses
Introduction to Clinical Pharmacology Chapter 33- Diuretics
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 12 Information Basic to Administering Drugs.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 9 Information Basic to Administering Drugs.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 41- Lower Gastrointestinal System.
Respiratory System Drugs Antitubercular Drugs. Tuberculosis (TB) Caused by Mycobacterium tuberculosis Antitubercular drugs treat all forms of Mycobacterium.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 04- The Nursing Process.
7. Anti-TB regimen in special situations of liver disease, renal impairment, and pregnancy.
Pulmonary TB. BY PROF. AZZA ELMedany Dr. Ishfaq Bukhari.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 30- Anticonvulsants.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs.
Introductory Clinical Pharmacology Chapter 34 Drugs Used to Treat Disorders of the Musculoskeletal System.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere.
ANTITUBERCULOUS DRUGS by Dr.Mohammed Abd-Almoneim
Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 7 Penicillins.
Module 4 Basic Principles of Treatment. “ubo! ubo! ubo!” (cough for 2 weeks or more) Did not take medication medication In Loving Memory of In Loving.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 22 Mobility and Safety.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 15 Antifungal Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy, and Mycobacterium avium Complex Infections.
Chemotherapy of Tuberculosis By Prof. Azza El-Medany.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 16 Antiparasitic Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Pulmonary TB. BY PROF.  AZZA ELMedany OBJECTIVES  At the end of lecture, the students should:  Discuss the etiology of tuberculosis  Discuss the.
Antitubercular Agents. Tuberculosis, “TB”Tuberculosis, “TB” Caused by Mycobacterium tuberculosisCaused by Mycobacterium tuberculosis Antitubercular agents.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Mycobacterial, Fungal, & Parasitic Infections Medications for Infection ADN 110/cohort 131.
Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 13 Leprostatic Drugs.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 41 Musculoskeletal Care Modalities.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
More Antibiotics Tutoring for Pharmacology
Treatment of TB Disease
Treatment of Latent TB Infection (LTBI)
Antiprotozoal Agents Chapter 12. Antiprotozoal Agents Chapter 12.
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
CNS Stimulants: Action #1
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Sulfonamides
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 42 Antidiabetic Drugs
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 33 Diuretics
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
TUBERCULOSIS Pulmonary TB Drug therapy Dr. Ishfaq Dr. Aliah.
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Cholinesterase Inhibitors: Actions and Uses
Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates
Introduction to Sedatives and Hypnotics #1
Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis
Presentation transcript:

Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs

Antitubercular Drugs: Actions and Uses Bacteriostatic against the M. tuberculosis bacillus: Act to inhibit bacterial cell wall synthesis, which slows the multiplication rate of the bacteria Used with other drugs to treat active TB— exception isoniazid (INH)

Antitubercular Drugs: Treatment Standard treatment: Initial phase Continuing phase Retreatment: Includes the use of four or more antitubercular drugs Treatment is individualized based on the susceptibility of the microorganism

Ethambutol: Adverse Reactions Generalized reactions: Dermatitis and pruritus; joint pain; anorexia; nausea and/or vomiting More severe reactions: Anaphylactoid reactions; optic neuritis

Ethambutol: Contraindications and Precautions Contraindicated in patients: With a history of hypersensitivity to the drug; younger than 13 years Used cautiously in patients: During pregnancy (pregnancy category B); with hepatic or renal impairment; with diabetic retinopathy or cataracts

Isoniazid: Adverse Reactions Generalized reactions: Nausea and/or vomiting; epigastric distress; fever; skin eruptions; hematologic changes; jaundice; hypersensitivity Toxicity: Peripheral neuropathy Severe, and sometimes fatal

Isoniazid: Contraindications and Precautions Contraindicated in patients: With a history of hypersensitivity to the drug Used cautiously in patients: During pregnancy (pregnancy category C) or lactation and in patients with hepatic and renal impairment

Isoniazid: Interactions Interactant drug Effect of interaction Aluminum salts Reduced absorption of isoniazid Anticoagulants Increased risk for bleeding Phenytoin (Dilantin) Increased serum levels of phenytoin Alcohol (in beverages) Higher incidence of drug-related hepatitis

Pyrazinamide: Adverse Reactions Generalized reactions: Nausea and/or vomiting; diarrhea; myalgia; rashes Hepatotoxicity: Symptoms may range from none (except for slightly abnormal hepatic function test results) to a more severe reaction such as jaundice

Pyrazinamide: Contraindications, Precautions, and Interactions Contraindicated in patients with known hypersensitivity to the drug; acute gout; severe hepatic damage Use cautiously in patients during pregnancy and lactation; with hepatic and renal impairment; with HIV; with diabetes mellitus Interaction: With allopurinol, colchicine, and/or probenecid—its effectiveness decreases

Rifampin: Adverse Reactions Generalized reactions: Nausea, vomiting Epigastric distress, heartburn, fatigue Vertigo, rash Reddish-orange discoloration of body fluids Hematologic changes, renal insufficiency

Rifampin: Contraindications, Precautions, and Interactions Contraindicated in patients with known hypersensitivity to the drug Used cautiously in patients with renal or hearing impairment; during pregnancy and lactation Interactions: With digoxin; oral contraceptives; isoniazid; oral anticoagulants; oral hypoglycemics; chloramphenicol; phenytoin; verapamil

Nursing Process: Assessment Preadministration assessment: Assess a family history and a history of contacts, if the patient has active TB Ongoing assessment: Observe the patient daily for the appearance of adverse reactions and report if found Carefully monitor vital signs daily

Nursing Process: Nursing Diagnoses Acute Pain Imbalanced Nutrition: Less Than Body Requirements Risk of Ineffective Self-Health Management

Nursing Process: Planning The expected outcome includes an optimal response to therapy: Management of adverse drug reactions Understanding of and compliance with the prescribed treatment regimen

Nursing Process: Implementation Promoting an optimal response to therapy: Allow time for the patient and family members to ask questions Refer the patient to other health care workers, such as a social service worker or a dietitian

Nursing Process: Implementation (cont.) Monitoring and managing patients’ needs: Acute Pain: Frequent parenteral injections Be careful to rotate the injection sites Inspect previous injection sites for signs of swelling, redness, and tenderness Notify if necessary

Nursing Process: Implementation (cont.) Monitoring and managing patients’ needs (cont.): Imbalanced Nutrition: Less Than Body Requirements Be aware of dosing regimen with/without food for ethambutol, pyrazinamide; monitor for gastric upset; use alternative dosing regimen or combination drugs; explain coloration of bodily fluids

Nursing Process: Implementation (cont.) Monitoring and managing patients’ needs (cont.): Ineffective Therapeutic Regimen Management: To help prevent the problem of noncompliance—directly observed therapy (DOT)

Nursing Process: Implementation (cont.) Educating the patient and family: Careful patient and family education and close medical supervision are necessary Explain that short-term therapy is of no value in treating this disease Remain alert for statements made by the patient or family that may indicate future noncompliance with the drug regimen

Nursing Process: Evaluation The therapeutic effect is achieved Adverse reactions are identified, reported, and managed successfully Pain or discomfort following IM or IV administration is relieved or eliminated Patient and family demonstrate understanding of the drug regimen Patient complies with the prescribed drug regimen

Question Is the following statement true or false? The nursing diagnosis of Ineffective Self-Health Management may be especially important with patients considering the short-term therapy required to treat TB.

Answer False The nursing diagnosis of Ineffective Self-Health Management may be especially important with patients considering the long-term therapy required to treat TB.

Question Is the following statement true or false? Directly observed therapy (DOT) involves a patient being directly watched by a health care provider when taking the antitubercular drugs.

Answer True Directly observed therapy (DOT) involves a patient being directly watched by a health care provider when taking the antitubercular drugs.

Question How long does a patient have to be on preventive therapy for exposure to tuberculosis? A. 1 month B. 2 months C. 4 months D. 6 months to 1 year

Answer D Preventive therapy (prophylaxis for those exposed but who do not have active disease) involves one drug taken for 6 months to 1 year.